Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm

Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S4, Page 3-11, October 2018.

Source: Asia-Pacific Journal of Clinical Oncology - October 5, 2018 Category: Cancer & Oncology Authors: Frances Boyle, Jane Beith, Katie Burslem, Richard Boer, Rina Hui, Elgene Lim, Nicole McCarthy, Andrew Redfern, Natasha Woodward Source Type: research